May measurement month 2017 campaign screening results from Venezuela: an analysis of blood pressure, abdominal circumference and body mass index. / Campaña de Medición del mes de mayo-2017: un análisis de los resultados de la presión arterial, circunferencia abdominal e índice de masa corporal en Venezuela.
Abstract
Abstract.
The present study had the purpose of evaluating the proportion of subjects with hypertension, treatment, control rates, and the relationship between blood pressure (BP) with body mass index and abdominal circumference in a cross-sectional study, as part of a worldwide study designed by International Society of Hypertension, performed during May 2017. After the protocol´s approval by the local Ethical Committee, 64 sites were included from eight Venezuelan regions. A short questionnaire was completed for each participant, including knowledge of taking antihypertensive treatment, diabetes, previous myocardial infarction or stroke, alcohol intake, and smoking. BP was measured in the sitting position three times after resting for 5 minutes, one minute apart, using mainly oscillometric devices. Height, weight and abdominal circumference were measured. Data analyses were performed by the MMM central team. 21644 individuals were screened. After multiple imputations, 10584 individuals [48.9% (50.7% male; 47.7% female)] had hypertension. Of subjects not receiving antihypertensive medication, 1538 (12.2%) were hypertensives. Of hypertensive individuals receiving antihypertensive medication, 2974 (32.9%) had uncontrolled BP. 15.6% of our sample had obesity according to their body mass index; 43.8% of women and 20.7% of men had abdominal obesity. BP was positively correlated with BMI and abdominal circumference. In this largest BP screening carried out in Venezuela, 48.9% of the individuals had elevated BP and 12.2% did not know that they had hypertension, and in one third of those with hypertension on treatment, BP was not controlled. 15.6% had obesity by BMI, and 35.1% abdominal obesity. Screening such as the MMM17 can evaluate the association between hypertension and obesity and therefore may help to inform control programs.
Resumen.
Se realizó el presente estudio con el objetivo de evaluar la proporción de sujetos con hipertensión, tratamiento, tasas de control y la relación entre la presión arterial (PA) con el índice de masa corporal y la circunferencia abdominal en un estudio transversal, como parte de un estudio mundial diseñado por la Sociedad Internacional de Hipertensión, realizada durante mayo de 2017. Luego de la aprobación del protocolo por el Comité de Ética local, se incluyeron 64 sitios de ocho regiones venezolanas. Se completó un breve cuestionario para cada participante, que incluye el conocimiento de tomar tratamiento antihipertensivo, diabetes, infarto de miocardio o accidente cerebrovascular previo, consumo de alcohol y tabaquismo. La PA se midió en posición sentada tres veces después de descansar durante 5 minutos, con un minuto de diferencia, utilizando principalmente dispositivos oscilométricos. Se midieron la talla, el peso y la circunferencia abdominal. Los análisis de datos fueron realizados por el equipo central de MMM. Se evaluaron 21644 personas. Después de múltiples imputaciones, 10584 individuos [48,9% (50,7% hombres; 47,7% mujeres)] tenían hipertensión. De los sujetos que no recibieron medicación antihipertensiva, 1538 (12,2%) eran hipertensos. De las personas hipertensas que recibieron medicamentos antihipertensivos, 2974 (32,9%) tenían BP no controlada. El 15,6% de nuestra muestra tenía obesidad según su índice de masa corporal; el 43,8% de las mujeres y el 20,7% de los hombres tenían obesidad abdominal. La PA se correlacionó positivamente con el IMC y la circunferencia abdominal. En esta encuesta de detección de la PA más grande realizada en Venezuela, el 48,9% de los individuos tenían presión arterial elevada y el 12,2% desconocían tener hipertensión, y en un tercio de aquellos con hipertensión en tratamiento, la PA no estaba controlada. El 15,6% tenía obesidad por IMC y el 35,1% obesidad abdominal. Los exámenes de detección como el MMM17 pueden estimar la prevalencia de hipertensión y obesidad y pueden ayudar a evaluar los programas de control.
Downloads
References
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Gras- si G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck- Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tende- ra M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosio- ni E, Lindholm LH, Viigimaa M, Adamo- poulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O’Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B, 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the ma- nagement of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105–1187.
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Es- tep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Baner- jee A, Bärnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catalá-López F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lo- pez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngale- soni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Se- panlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimpa- ris N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemo- to N, Zaki ME, Murray CJ. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA 2017; 317: 165–182.
World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011. www.who.int/nmh/publications/ncd_re- port_full_en.pdf
Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, To- rres M, Hernandez R, Wilson E. Prevalence of the metabolic syndrome in Latin Ameri- ca and its association with sub-clinical ca- rotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol 2009; 26:8–52.
Granero R, Infante E. Four decades on cardiovascular diseases mortality in Ve- nezuela, 1965-2007 Avances Cardiol 2011;31(2):102-107.
Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S, and INTER- HEART Investigators in Latin America. Risk factors for acute myocardial infarc- tion in Latin America: the INTERHEART Latin American study. Circulation 2007; 115:1067–1074.
Williams B, Mancia G, Spiering W, Agabi- ti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilo- pe L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmie- der RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39:3021-3104.
Task Force of the Latin American Society of Hypertension, Guidelines on the Mana- gement of arterial hypertension and related comorbidities in Latin America. J Hyper- tens 2017;35:1529-1545.
Hernández-Hernández R, Silva H, Velasco M, Pellegrini F, Macchia A, Escobedo J, Vinueza R, Schargrodsky H, Champagne B, Prampa- ro P, Wilson E, Carmela Study Investigators. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Eva- luation in Latin America (CARMELA) study. J Hypertens 2010; 28:24–34.
Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Sil- va Ayçaguer LC, Touboul PJ, Boissonnet CP, Escobedo J, Pellegrini F, Macchia A, Wilson E; CARMELA Study Investigators. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008; 121:58–65.
Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, Charchar FJ, Damasceno A, Kruger R, Lackland DT, Nilsson PM, Prabhakaran D, Ramirez AJ, Schlaich MP, Wang J, Weber MA, Poulter NR; MMM Investigators. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6:e736-e743.
WHO. Physical status: the use and interpre- tation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva: World Health Organiza- tion, 1995.
Surveillance Epidemiology and End Re- sults (SEER) Program. Standard popula- tions—single ages. 2013. https://seer.can- cer.gov/stdpopulations/stdpop.singleages. html (accessed Feb 20, 2018).
Hernández-Hernández R, Chacon-Ramirez LA, Hernández-Faraco A. Estudio de la pre- valencia de hipertensión en Barquisimeto (Estado Lara). Boletín Médico de Postgrado 1994;10:223-233.
Sulbaran T, Vargas AM, Calmón GE. Epi- demiology of arterial hypertension in adult population of Maracaibo, Venezuela. Invest Clin 1997;38:3-11.
López-Nouel R, Hurtado D, López-Gómez L, Acosta-Martínez J, Chazzin G, Castillo E, Marques J. Una aproximación a cono- cer la prevalencia de hipertensión arterial, factores de riesgo cardiovascular y esti- lo de vida en Venezuela. Avances Cardiol 2014;34:128-134.
Silva H, Hernandez-Hernandez R, Vinueza R, Velasco M, Boissonnet CP, Escobedo J, Silva HE, Pramparo P, Wilson E; CARME- LA Study Investigators. Cardiovascular risk awareness, treatment, and control in urban Latin America. Am J Ther 2010;17:159-166
Anuario de Mortalidad 2013. Ministerio del Poder Popular para la Salud. República Bolivariana de Venezuela. Disponible en: http://www.ovsalud.org/descargas/publica- ciones/documentos-oficiales/Anuario-Mor- talidad-2013.pdf
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC,Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT. 2017 ACC/AHA/AAPA/ ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, De- tection, Evaluation, and Management of High Blood Pressure in Adults. Ame- rican College of Cardiology (2017), doi: 10.1016/j.jacc.2017.11.006.
The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-2116.
Hernández-Hernández R, López Rivera JA, Octavio Seijas JA. II Norma venezolana para el monitoreo ambulatorio de presión arterial y automedición de presión arterial. Avances Cardiológicos: 2011; 31:15-34.
Nieto-Martínez R, Marulanda MI, Gonzá- lez- Rivas JP, Ugel E, Durán M, Barengo N, Aschner P, Patiño M, López Gómez L, Monsalve P, Marcano H, Florez H. Car- dio-metabolic health Venezuelan study (EVESCAM): Design and implementation. Invest Clin 2017; 58: 56–61.
González-Rivas J, Mechanick J, Duran M, Ugel E, Marulanda M, Nieto-Martínez R. Re-classifying hypertension in the Venezue- lan EVESCAM Database using 2017 AHA/ ACC criteria: high prevalence, poor con- trol, and urgent call for action. Ann Global Health 2019; 85(1) 74: 1–8.
Hernández-Hernández R. Obesity the most influencing and modifiable risk factors in La- tin America (Abstract) International Society of Hypertension Meeting 2016. J Hypertens September 2016, Vol. 34, Issue p e6.
Bermúdez V, Pacheco M, Rojas J, Córdo- va E, Velázquez R, Carrillo D, Parra MG, Toledo A, Añez R, Fonseca E, Marcano RP, Cano C, Miranda JL. Epidemiologic beha- viour of obesity in Maracaibo city metabo- lic syndrome prevalence study. PloS One 2012;7:e35392.
Aucott LS, Poobalan, AS, Smith WCS, Ave- nell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes. A syste- matic review. Hypertension 2005;45:1035- 1041.
Caraballo-Arias Y. Occupational safety and health in Venezuela. Ann Global Health 2015;81:512-521.
Requena J. Economy crisis: Venezuela´s brain drain is accelerating. Nature 2016; 536:3969.
Nieto-Martinez R, González-Rivas JP, Li- ma-Martínez M, Stepenka V. Rísquez A, Mechanick JI. Diabetes care in Venezuela, Ann Glob Health 2015;81:776-791.
Escobedo J, Buitrón LV, Velasco M, Ramí- rez C, Hernández R, Macchia A, Pellegrini F, Schargrodsky H, Boissonnet C, Cham- pagne BM and CARMELA Study Inves- tigators. High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA Study. Diabet Med 2009;26:864-871.
